Stockscreener 앱 받기
2.16
2.37%
0.05
시간 외 거래:
2.10
-0.06
-2.78%
Ensysce Biosciences Inc 주식(ENSC)의 최신 뉴스
Ensysce Biosciences initiates Phase 3 study of PF614 - TipRanks
FDA-Reviewed Phase 3 Trial Begins: Revolutionary Opioid Promises Pain Relief Without Abuse Risk - Stock Titan
Why Ensysce Biosciences Inc. stock attracts strong analyst attentionInvestor Friendly Risk Reward - Newser
What makes Ensysce Biosciences Inc. stock price move sharplySteady Income Ideas - Newser
NAVY(boat pilot token) Tokenomics ExplainedHigh Return Potential - Newser
How Ensysce Biosciences Inc. stock performs during market volatilityVolume Spike Monitors - Newser
Where are the Opportunities in (ENSC) - news.stocktradersdaily.com
Travere Therapeutics (NASDAQ:TVTX) and Ensysce Biosciences (NASDAQ:ENSC) Head to Head Comparison - Defense World
FDA-Designated Breakthrough Pain Drug Advances: New Solution to Opioid Overdose Crisis Shows Promise - Stock Titan
(ENSC) Investment Analysis - news.stocktradersdaily.com
Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World
Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan
(ENSC) On The My Stocks Page - news.stocktradersdaily.com
Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World
ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa
ensysce biosciences appoints baker tilly as new auditor - Investing.com
Ensysce Flat on Receiving Grant - Baystreet.ca
Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia
Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada
Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus
Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan
Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World
When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com
Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World
Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks
Ensysce Biosciences: Is Now the Time to Bet on a Turnaround? - AInvest
Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan
Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan
Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $4.7 Million Gross Proceeds - ACCESS Newswire
(ENSC) Trading Signals - news.stocktradersdaily.com
Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants - ACCESS Newswire
Ensysce Biosciences Announces Pricing of $4.1 Million Public Offering - ACCESS Newswire
Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire
Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - ACCESS Newswire
Ensysce Biosciences Inc (ENSC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
Ensysce Biosciences Secures $2.2M Funding Boost: Key Details on TAAP/MPAR Program Advancement - Stock Titan
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds - MSN
For Array Technologies Inc [ARRY], Analyst sees a rise to $7. What next? - dbtnews.com
ENSC’s Future Brightens: A Swing to Watch? - StocksToTrade
Ensysce Biosciences (ENSC) Stock Surges on Patent News - GuruFocus
Ensysce Biosciences (ENSC) Secures $2.2 Million Through Warrant Exercise - GuruFocus
Ensysce Biosciences to raise $2.2 million through warrant exercise By Investing.com - Investing.com Canada
Ensysce Biosciences secures patent for OUD treatment By Investing.com - Investing.com South Africa
Ensysce Biosciences Stock Doubles In One Trading SessionHere's Why - AOL.com
3.40%
2.49%
자본화:
|
볼륨(24시간):